Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110506 | PMC |
| http://dx.doi.org/10.1007/s00109-022-02203-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Erratum: Addendum: A novel N-Arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization.
Front Pharmacol
January 2023
Department of Respiratory Medicine, The Second Hospital of Jilin University, Jilin, China.
[This corrects the article DOI: 10.3389/fphar.2022.
View Article and Find Full Text PDFCorrigendum: A novel N-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization.
Front Pharmacol
January 2023
Department of Respiratory Medicine, The Second Hospital of Jilin University, Jilin, China.
[This corrects the article DOI: 10.3389/fphar.2022.
View Article and Find Full Text PDFCorrigendum: ASK1-interacting protein 1 acts as a novel predictor of type 2 diabetes.
Front Endocrinol (Lausanne)
August 2022
Center for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
[This corrects the article DOI: 10.3389/fendo.2022.
View Article and Find Full Text PDFCorrection to: ASK1 is a novel molecular target for preventing aminoglycoside‑induced hair cell death.
J Mol Med (Berl)
May 2022
Bruce Lefroy Centre, Murdoch Children's Research Institute, Parkville, VIC, Australia.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!